Adam Barrows is a Clinical Trial Lead/Study Director for Bristol-Myers Squibb working in Oncology Clinical Development working on Immuno-Oncology agents in the Emerging Tumors team. Adam started his career in clinical research working for ICON Clinical Research in data management and study start-up. Following his time at ICON, he worked in clinical pharmacology at Wyeth then trial operations at Merck. Having spent the majority of his clinical research profession in clinical operations Adam has shifted his focus to strategic trial design and execution as part of the clinical development team at BMS. As a passionate researcher, Adam has worked across multiple therapeutic areas in every phase of clinical research, from start-up to study closeout and brings his operational skills to the scientific execution of clinical trials.